New Trends in Drug Development:
Companion Diagnostics

SABPA Science & Technology Forum

03/19/2011 08:30 a.m. - 12:30 p.m.

Life Sciences + Healthcare

Institute of the Americas
University of California, San Diego
La Jolla, CA 92037


Peng Chen will be speaking at the SABPA Science & Technology Forum, “New Trends in Drug Development: Companion Diagnostics.” Companion diagnostics, which looks for genetic, protein, or gene expression markers to predict whether a drug works in someone or causes an adverse effect, has emerged into an exciting new trend over the last few years. With the cost and hurdles to get a new drug approved increasing, more and more pharma companies are using companion tests to develop safer and more effective drugs. The value of companion diagnostic tests has already been proven by a number of marketed products, yet despite the proven successes and wider awareness of companion diagnostics, pharma companies still move slowly in adopting the new paradigm to co-develop new drugs along with the companion tests. The SABPA Science & Technology Forum convenes a forum to discuss this rapidly growing field.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2019 Morrison & Foerster LLP. All rights reserved.